As of 2024-10-12, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 5.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.92 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is -64.1%.
The range of the Relative Valuation is 4.77 - 8.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 46.1x | 30.6x |
| Forward P/E multiples | 25.9x - 30.7x | 27.6x |
| Fair Price | 4.77 - 8.48 | 5.36 |
| Upside | -68.0% - -43.1% | -64.1% |
| Date | P/E |
| 2024-10-11 | 81.04 |
| 2024-10-10 | 79.03 |
| 2024-10-09 | 79.24 |
| 2024-10-08 | 78.54 |
| 2024-10-07 | 80.00 |
| 2024-10-04 | 82.01 |
| 2024-10-03 | 79.95 |
| 2024-10-02 | 82.18 |
| 2024-10-01 | 83.10 |
| 2024-09-30 | 83.53 |
| 2024-09-27 | 85.22 |
| 2024-09-26 | 84.08 |
| 2024-09-25 | 83.21 |
| 2024-09-24 | 86.03 |
| 2024-09-23 | 88.48 |
| 2024-09-20 | 89.78 |
| 2024-09-19 | 89.18 |
| 2024-09-18 | 88.69 |
| 2024-09-17 | 88.31 |
| 2024-09-16 | 87.66 |
| 2024-09-13 | 88.64 |
| 2024-09-12 | 86.63 |
| 2024-09-11 | 86.63 |
| 2024-09-10 | 84.89 |
| 2024-09-09 | 85.65 |
| 2024-09-06 | 87.28 |
| 2024-09-05 | 88.10 |
| 2024-09-04 | 90.65 |
| 2024-09-03 | 88.86 |
| 2024-08-30 | 90.05 |
| 2024-08-29 | 88.64 |
| 2024-08-28 | 85.27 |
| 2024-08-27 | 85.54 |
| 2024-08-26 | 87.39 |
| 2024-08-23 | 86.58 |
| 2024-08-22 | 85.16 |
| 2024-08-21 | 86.52 |
| 2024-08-20 | 84.57 |
| 2024-08-19 | 85.60 |
| 2024-08-16 | 83.64 |
| 2024-08-15 | 83.64 |
| 2024-08-14 | 82.23 |
| 2024-08-13 | 85.44 |
| 2024-08-12 | 83.05 |
| 2024-08-09 | 84.89 |
| 2024-08-08 | 85.35 |
| 2024-08-07 | 82.39 |
| 2024-08-06 | 102.38 |
| 2024-08-05 | 99.99 |
| 2024-08-02 | 101.95 |